Monogram Health, a Nashville, TN-based provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, raised $375M in Growth funding.
The round was led by CVS Health, Cigna Ventures, Humana, Memorial Hermann Health System, SCAN, TPG Capital, Frist Cressey Ventures, Heritage Group, Pura Vida Investments, and Norwest Venture Partners.
Led by CEO Mike Uchrin, Monogram Health is a value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease. The company deploys an innovative in-home care delivery model and technology-driven array of evidence-based clinical services, including complex case and disease management, utilization management, and medication therapy management. Monogram Health has numerous value-based partnerships with health plans and risk-bearing providers to care for patients across 34 states and all insurance products.
The company intends to use the funds to continue to support the widespread deployment of its in-home kidney and polychronic care delivery model as well as its tech-driven array of evidence-based clinical services.